site background
Skip to content
Ivy Brain Tumor Center
Main Menu
  • ESPAÑOL
  • Donate
  • Blog
  • TRIAL ELIGIBILITY
Talk to an Ivy Navigator
  • Brain Tumor Care
    • Tumor Types
      • Glioblastoma
      • Gliomas
      • Brain Metastases
      • Meningiomas
      • Other Tumors
    • Brain Tumor Treatment
      • Neurosurgery
      • Neuro-Oncology
      • Radiation Oncology
      • Neuroimaging
    • Supportive Care
      • Neuro-Rehabilitation
      • Neuropsychology
      • Palliative Care
      • Support Groups
      • Social Work Services
  • Clinical Trials
    • Current Trials
    • Phase 0 Clinical Trials
    • Trial Screening
  • Our Specialists
  • Patient & Caregiver Resources
    • Advocacy & Support Groups
    • Patient & Visitor Information
      • Lodging
      • Transportation
    • Patient Stories
    • Blog
  • Research
    • Scientific Cores
    • Labs
    • Certifications
    • Preclinical Research
    • Industry Partnerships
    • Published Research
  • About
    • Newsroom
    • Careers
    • How You Can Help
    • Events
    • Contact Us

Talk to an Ivy Navigator

602-406-8605
About Team Susan Chang, MD
Headshot of Susan Chang

Susan Chang, MD

Scientific Advisory Board Member

Susan Chang, M.D., is Professor in the Department of Neurological Surgery at the University of California at San Francisco (UCSF) and holds the Lai Wan Kan Endowed Chair. She is an investigator in the Brain Tumor Center and is co-leader of the Neuro-Oncology Program at the Helen Diller Family Comprehensive Cancer Center. 

Dr. Chang is an internationally recognized leader in the field of neurological malignancies. She specializes in the treatment of adults with brain tumors, including glioblastomas and meningiomas. Dr. Chang’s major research focus is on the development of novel therapies for brain tumor patients in addition to the assessment of novel imaging markers of prognosis and treatment response. She is the co-principal investigator of a UCSF SPORE project evaluating the role of magnetic resonance spectroscopy in diagnosing tumors and evaluating therapeutic interventions. She is also the principal investigator for a program project grant (P01) focusing on noninvasive markers of molecular subtypes of glioma. She is a member of the executive committee for the Response Assessment in NeuroOncology (RANO) group and has served in many leadership roles in the Society for NeuroOncology including President.  In 2022, Dr. Chang was appointed as Editor-in-Chief of the journal Neuro-Oncology.

Dr. Chang is especially dedicated to improving the experience of her patients and their families, with a particular focus on increasing their quality of life. She is the medical director of the UCSF Neuro-Oncology Gordon Murray Caregiver Program, developed to address the needs of family members and others who care for patients with brain tumors. She is also the co-director of the Sheri Sobrato Brisson Brain Cancer Survivorship Program focused on comprehensive survivorship care for brain tumor patients.

Dr. Chang received her medical degree from the University of British Columbia and completed a residency in internal medicine at Plains Health Centre and Toronto General Hospital. She completed a fellowship in medical oncology at Princess Margaret Hospital in Toronto, as well as a fellowship in neuro-oncology at UCSF, subsequently joining as faculty.

Back to Top
St Joesph Hospital

Stay Informed

Stay up to date on the latest in brain tumor research, treatment and community events.

Ivy Brain Tumor Center

About Ivy Brain Tumor Center

The Ivy Brain Tumor Center at Barrow Neurological Institute in Phoenix, AZ, is a tertiary care and nonprofit translational research program that employs bold, early-phase clinical trial strategies to identify new treatments for aggressive brain tumors, including glioblastoma. Our leading experts in neurosurgical oncology, neuro-oncology, radiation oncology, neuroradiology, neuropathology and neuroscience nursing treat more patients annually than any other brain tumor center in the United States. The Ivy Center’s Phase 0 clinical trials program is the largest in the world and enables personalized care in a fraction of the time and cost associated with traditional drug development. In addition, unlike conventional clinical trials focusing on single drugs, the Ivy Center’s accelerated program tests therapeutic combinations matched to individual patients. We leave no stone unturned in the pursuit of hope and healing.

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

2910 North Third Avenue
Phoenix, Arizona 85013
(602) 406-6489
[email protected]
Mailing Address for Donations »

Barrow Neurological Institute

HIPAA Notice of Privacy Practices  |  Legal Notices  | Internet Privacy Notice  |  Online Accessibility Notice  |  Organized Health Care Arrangement (OHCA)

Patient Rights and Responsibilities  |  Site Map

© 2024 Ivy Brain Tumor Center

Important Notice

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device.